GENE ONLINE|News &
Opinion
Blog

Uncategorized
CanSinoBIO’s COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
2022-05-19
Leading HealthTech AI company NuraLogix announces new partnership with LaFiya TeleHealth
2022-05-05
The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine
2022-04-28
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial
2022-04-26
Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress
2022-04-26
DetectedX and GE Healthcare Enter Mammography Education Partnership to Improve Accuracy and Better Inform Clinical Decisions
2022-04-25
AACR 2022: Stand Up to Cancer, Standing up to Treatment
2022-04-21
FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies
2022-04-19
Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19
2022-04-19
A Brainwave Technology from Hyundai Mobis Proven to Reduce Drowsiness and Inattentive Driving by Up to 1/3
2022-04-18
World Hemophilia Day 2022 – “Access for All: Partnership. Policy. Progress. Engaging your government, integrating inherited bleeding disorders into national policy”
2022-04-17
AACR 2022: Ascentage Pharma Presents Latest Results from Six Preclinical Studies
2022-04-13
Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW004, an oral tablet formulation of its Proprietary GLP-1 Analogue (Ecnoglutide)
2022-04-13
111, Inc. Provides Urgently-needed Items and Online Services to Support Shanghai’s Fight Against Covid-19 Pandemic
2022-04-13
CStone Announces Presentation of Preclinical data on a Multi-Specific Antibody-based Therapeutic Candidate CS2006/NM21-1480 at the American Association for Cancer Research (AACR) Annual Meeting 2022
2022-04-12
1 2 3 4
LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top